Showing 1-10 of 23 results for "".

• “Turn-Key” Hair Restoration Requires Caution: The Specialist's Perspective

  https://modernaesthetics.com/ma-issues-index/2019-july-aug/turn-key-hair-restoration-requires-caution-the-specialists-perspective/34023/
  Surgeons must protect their role and establish their expertise now and for the future.
  • Text
• Jeffrey Epstein, MD
  https://modernaesthetics.com/profiles/jeffrey-epstein-md/LqJGVB/
• Jeffrey Epstein, MD, FACS, FISHRS
  https://modernaesthetics.com/profiles/jeffrey-epstein-md-facs-fishrs/j5eaMx/

• MATV News Extra: Daxxify Q&A with Dr. Jeffrey Dover

  https://modernaesthetics.com/series/matv-news/matv-news-extra-daxxify-qa-with-dr-jeffrey-dover/33704/
  The FDA has approved Revance Therapeutics’ Daxxify (daxibotulinumtoxinA-lanm) for injection for the temporary improvement of moderate to severe glabellar lines in adults. Dermatologists and clinical trial investigator Jeffrey Dover, MD sat down with MATV News to share insights into the SAKURA Phase
  • Video

• MATV News: Revance’s Daxxify Approved; ASPS Data Show Cosmetic Surgery Booming; DREAM Initiative Supports Residency Curriculum for Advancing Racial Equity

  https://modernaesthetics.com/series/matv-news/matv-news-revances-daxxify-approved-asps-data-show-cosmetic-surgery-booming-dream-initiative-supports-residency-curriculum-for-advancing-racial-equity/33703/
  Revance Therapeutics’ Daxxify (daxibotulinumtoxinA-lanm) wins FDA approval for the temporary improvement of moderate to severe glabellar lines in adults. Clinical trial investigator Jeffrey Dover, MD discusses Daxxify’s unique Peptide Exchange Technology (PXT) and long-lasting effects. New data from
  • Video

• Profiles in Innovation: David E. Kent, MD

  https://modernaesthetics.com/topics/energy-based-devices/profiles-in-innovation-david-e-kent-md/34909/
  • Text

• Pro Tips: Starting Your Private Practice

  https://modernaesthetics.com/ma-issues-index/2023-sept-oct/pro-tips-starting-your-private-practice/35315/
  Sarah Jackson, MD, and Deirdre Hooper, MD, share startup lessons with members of Modern Aesthetics’ peer-to-peer networking program, YoungMD Connect
  • Text

• The New Age of Devices: Challenges and Opportunities

  https://modernaesthetics.com/ma-issues-index/2015-july-aug/the-new-age-of-devices-challenges-and-opportunities/34496/
  Experts featured on ModernAesthetics.TV discuss the device spectrum and share tips for best results.
  • Text

• Hypochlorous Acid (HOCl): An Important Emerging Option for Periprocedural Care

  https://modernaesthetics.com/ma-supplements/2018-may-june-insert/hypochlorous-acid-hocspan-class-charoverride-2lspan-an-important-emerging-option-for-periprocedural-care/34125/
  • Text

• Remembering Melanie Grossman, MD

  https://modernaesthetics.com/ma-issues-index/2021-may-june/remembering-melanie-grossman-md/35051/
  • Text

• Prev
• 1
• 2
• 3
• Next